FCH
BIIB icon

Freestone Capital Holdings’s Biogen BIIB Stock Holding History

Freestone Capital Holdings’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,036
Closed -$218K – 445
2022
Q1 		$218K Buy
1,036
+11
+1% +$2.39K 0.01% 527
2021
Q4 		$246K Buy
1,025
+126
+14% +$32.4K 0.01% 436
2021
Q3 		$254K Sell
899
-24
-3% -$7.87K 0.01% 373
2021
Q2 		$320K Sell
923
-128
-12% -$38.8K 0.02% 328
2021
Q1 		$294K Buy
1,051
+58
+6% +$15.6K 0.02% 332
2020
Q4 		$243K Sell
993
-185
-16% -$47.7K 0.01% 323
2020
Q3 		$334K Sell
1,178
-178
-13% -$49.6K 0.02% 262
2020
Q2 		$363 Sell
1,356
-213
-14% -$64K ﹤0.01% 264
2020
Q1 		$496 Sell
1,569
-1,240
-44% -$376K 0.01% 250
2019
Q4 		$834 Sell
2,809
-1,685
-37% -$468K 0.02% 276
2019
Q3 		$1.05K Sell
4,494
-1,326
-23% -$309K 0.03% 256
2019
Q2 		$1.36K Sell
5,820
-30,245
-84% -$6.98M 0.03% 201
2019
Q1 		$8.53M Buy
36,065
+1,367
+4% +$430K 0.51% 56
2018
Q4 		$10.4M Sell
34,698
-15,269
-31% -$4.87M 0.71% 37
2018
Q3 		$17.7M Buy
49,967
+40,645
+436% +$14M 0.11% 33
2018
Q2 		$2.71M Buy
+9,322
New +$2.62M 0.02% 140
2017
Q2 		– Sell
-2,064
Closed -$564K – 339
2017
Q1 		$564K Sell
2,064
-258
-11% -$72.9K 0.04% 260
2016
Q4 		$659K Buy
+2,322
New +$688K 0.06% 236
2013
Q3 		– Sell
-3,544
Closed -$763K – 363
2013
Q2 		$763K Buy
+3,544
New +$757K 0.16% 120

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Freestone Capital Holdings's BIIB Position: Q2 2022 in Review

Freestone Capital Holdings sold out of Biogen (BIIB) in Q2 2022, closing a stake of 1,036 shares — an estimated $218K sold.

Freestone Capital Holdings first reported a position in BIIB in Q2 2013 and held it in 19 quarters. The position peaked at $17.7M in Q3 2018. 927 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

  • Freestone Capital Holdings reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
  • Freestone Capital Holdings sold 1,036 Biogen shares in Q2 2022, an estimated $218K.
  • Freestone Capital Holdings first reported a position in Biogen in Q2 2013 and held it in 19 quarters.
  • Freestone Capital Holdings's Biogen position peaked at $17.7M in Q3 2018.
  • 927 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on Freestone Capital Holdings's 13F filing for Q2 2022, filed 9 Aug 2022.